Overview

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

Status:
Completed

Trial end date:
2018-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of addition of everolimus to letrozole with LHRH agonist in premenopausal metastatic breast cancer patients who failed to tamoxifen treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Asan Medical Center

Treatments:

Everolimus
Letrozole
Leuprolide
Sirolimus